Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

Call out to the next generation of digital innovations to transform health and care

18 May 2020
Applications are now open for the DigitalHealth.London Accelerator programme, closing midnight Sunday 5 July 2020.

Digital products and services are currently providing vital innovation, support and capacity to the NHS during the response to COVID-19. Today, our DigitalHealth.London programme has opened applications to join its Accelerator, supporting the next generation of digital health companies to transform health and care.

Now in its fifth consecutive year, the programme, which is delivered collaboratively by MedCity, UCLPartners, Imperial College Health Partners, and the Health Innovation Network, has supported some of the biggest and most effective digital innovations being used by the NHS in London. To date the Accelerator has supported 105 innovative digital health companies, with 160 additional NHS contracts signed by those companies. For every £1 spent on the programme it is estimated over £14 is saved for the NHS.

DigitalHealth.London’s Accelerator aims to speed up the adoption of technology in London’s NHS, relieving high pressure on services and empowering patients to manage their health. It works with up to 20 high potential SMEs over a 12-month period, giving bespoke support and advice, a programme of expert-led workshops and events and brokering meaningful connections between innovators and NHS organisations with specific challenges. The companies that are successful in getting onto the Accelerator programme are chosen through a rigorous and highly competitive selection process, involving expert NHS and industry panel assessments, interviews and due diligence checks. Companies that have a product or solution that is well-defined and are ready to start building their evidence base are likely to benefit the most from the type of support offered through the programme. Through-out the 12 months the programme focuses on engagement with different elements of the health and care system. Company suitability is assessed based both on product maturity (meaning products that are ready to be trailed or bought that have high potential to meet NHS challenges) and on the company’s capacity to benefit from the programme (meaning companies have enough time and staff to engage).

Find out more: DigitalHealth.London/Accelerator

Join the webinar:

Ask Questions during the Twitter Live Q&A on Thursday 21 May 2020 between 2-3pm. Tag @DHealthLDN and use the hashtag: #DHLAQandA